JPMorgan Chase has promoted two London-based bankers, James Capper and George Pissanos, as part of a significant reorganisation of its healthcare investment banking team, according to an internal memo seen by Financial News. The moves are designed to bolster the bank's expertise in the healthcare sector amid a wave of dealmaking.
New Roles for Capper and Pissanos
James Capper has been appointed as head of healthcare investment banking for Europe, the Middle East and Africa (EMEA), while George Pissanos will serve as head of healthcare for the UK and Ireland. Both will report to Chris Sim, JPMorgan's head of EMEA healthcare investment banking.
The promotions come as JPMorgan reshuffles its healthcare team globally, creating a more integrated structure across regions. The bank is looking to capture more mandates in the pharmaceutical, biotech, and medical technology sectors, which have seen robust activity driven by innovation and consolidation.
Strategic Focus on Healthcare
Healthcare has been a key focus for JPMorgan, with the bank advising on several high-profile deals in recent years. The reorganisation aims to leverage the expertise of senior bankers like Capper and Pissanos to deepen client relationships and win new business. Both bankers have extensive experience in the sector, having worked on transactions involving companies such as GlaxoSmithKline, AstraZeneca, and Roche.
JPMorgan's healthcare team in London has been a hub for the bank's European operations, and the promotions underscore the importance of the UK market despite Brexit uncertainties. The bank continues to invest in its London office, which remains a critical centre for its investment banking activities.
Broader Team Changes
The shake-up also includes the appointment of new heads for healthcare in other regions, such as Asia Pacific and the Americas. This global coordination is expected to enhance the bank's ability to serve multinational clients and cross-border transactions. JPMorgan has been actively recruiting and promoting talent in healthcare banking, reflecting the sector's resilience and growth prospects.
The internal memo, signed by Chris Sim and other senior leaders, highlighted the bank's commitment to healthcare and its confidence in the newly appointed leaders. It stated that the changes would take immediate effect.
JPMorgan's move comes amid a broader trend of banks reorganising their healthcare teams to adapt to changing market dynamics. The sector has seen increased merger and acquisition activity, as well as fundraising by biotech firms, creating opportunities for investment banks.
